Inventor · disambiguated record
Badreddin Edris
Also filed as: EDRIS BADREDDIN
0 granted patents·10 pending applications·0 citations·filing 2013–2023
Files withOPI VI IP HOLDCO LLC3EDGEWISE THERAPEUTICS INC2SPRINGWORKS THERAPEUTICS INC2BEIGENE LTD1SILVERBACK THERAPEUTICS INC1
Top patents by PatentIndex Score
10 records- 0165US2022362242A1Methods and compositions for treating movement disordersEDGEWISE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0260US2023293464A1Treatment of pancreatic ductal adenocarcinoma with mirdametinibSPRINGWORKS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0360US2021139604A1Compositions of antibody construct-agonist conjugates and methods of use thereofOPI VI IP HOLDCO LLC·Filed 2020·Application pending·0 cites
- 0457US2021060012A1Methods and compositions for treating movement disordersEDGEWISE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0555US2023121547A1A combination therapy with nirogacestat and a bcma-directed therapy and uses thereofSPRINGWORKS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0652US2017298139A1Compositions of antibody construct-agonist conjugates and methods of use thereofOPI VI - IP HOLDCO LLC·Filed 2017·Application pending·0 cites
- 0752US2023128315A1Co-administration of mirdametinib and lifirafenib for use in treating cancersBEIGENE LTD·Filed 2021·Application pending·0 cites
- 0849US2017158772A1Compositions of antibody construct - agonist conjugates and methods of use thereofOPI VI - IP HOLDCO LLC·Filed 2016·Application pending·0 cites
- 0943US2020199247A1Antibody conjugates of immune-modulatory compounds and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1040US2014322234A1Analysis and Targeting of ROR2 in CancerUNIV LELAND STANFORD JUNIOR·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Badreddin Edris files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →